D. Choquette

5.9k total citations
99 papers, 4.1k citations indexed

About

D. Choquette is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, D. Choquette has authored 99 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Rheumatology, 23 papers in Immunology and 19 papers in Genetics. Recurrent topics in D. Choquette's work include Rheumatoid Arthritis Research and Therapies (50 papers), Systemic Lupus Erythematosus Research (24 papers) and Osteoarthritis Treatment and Mechanisms (20 papers). D. Choquette is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (50 papers), Systemic Lupus Erythematosus Research (24 papers) and Osteoarthritis Treatment and Mechanisms (20 papers). D. Choquette collaborates with scholars based in Canada, United States and United Kingdom. D. Choquette's co-authors include Boulos Haraoui, Johanne Martel‐Pelletier, Gary A. Cline, Jean‐Pierre Pelletier, F. Abram, Jean‐Pierre Raynauld, J-P Pelletier, John M. Esdaile, John F. Beary and Marie-Josée Berthiaume and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and The American Journal of Medicine.

In The Last Decade

D. Choquette

93 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Choquette Canada	32	3.1k	1.3k	655	547	526	99	4.1k
M Dougados France	20	2.8k 0.9×	1.0k 0.8×	611 0.9×	459 0.8×	181 0.3×	36	3.8k
Santos Castañeda Spain	38	3.1k 1.0×	722 0.6×	1.2k 1.8×	623 1.1×	241 0.5×	298	5.6k
Helen Keen Australia	33	2.7k 0.9×	996 0.8×	502 0.8×	315 0.6×	176 0.3×	157	4.1k
Yanyan Zhu United States	28	1.7k 0.5×	1.8k 1.4×	287 0.4×	520 1.0×	474 0.9×	83	4.9k
Louis Bessette Canada	35	2.4k 0.8×	1.5k 1.1×	891 1.4×	828 1.5×	91 0.2×	175	5.2k
D. van der Heijde Netherlands	22	2.7k 0.9×	576 0.4×	555 0.8×	195 0.4×	102 0.2×	36	3.2k
Ole Rintek Madsen Denmark	29	1.4k 0.5×	499 0.4×	371 0.6×	510 0.9×	169 0.3×	94	2.5k
Kim Hørslev‐Petersen Denmark	39	2.8k 0.9×	538 0.4×	735 1.1×	388 0.7×	97 0.2×	194	4.6k
Martin Soubrier France	42	3.5k 1.1×	1.3k 1.0×	1.1k 1.6×	381 0.7×	91 0.2×	300	6.7k
Alfons A den Broeder Netherlands	39	3.5k 1.1×	708 0.5×	1.3k 1.9×	146 0.3×	114 0.2×	225	5.0k

Countries citing papers authored by D. Choquette

Since Specialization

Citations

This map shows the geographic impact of D. Choquette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Choquette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Choquette more than expected).

Fields of papers citing papers by D. Choquette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Choquette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Choquette. The network helps show where D. Choquette may publish in the future.

Co-authorship network of co-authors of D. Choquette

This figure shows the co-authorship network connecting the top 25 collaborators of D. Choquette. A scholar is included among the top collaborators of D. Choquette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Choquette. D. Choquette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Birck, Marina Gabriela, D. Choquette, Gilles Boire, et al.. (2024). Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data. BMC Rheumatology. 8(1). 47–47.

Gladman, Dafna D., Vinod Chandran, Cheryl F. Rosen, et al.. (2024). Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA). The Journal of Rheumatology. 51(5). 479–487. 2 indexed citations

Movahedi, Mohammad, D. Choquette, Louis Coupal, et al.. (2023). Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada. BMJ Open. 13(3). e063198–e063198. 4 indexed citations

Inman, Robert D., et al.. (2023). Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network. The Journal of Rheumatology. 50(5). 634–640. 2 indexed citations

Coupal, Louis, et al.. (2023). POS0325 RHEUMATOID ARTHRITIS PATIENTS AND WEATHER PATTERNS: A RHUMADATA™ STUDY OF 14,200 PATIENT-REPORTED OUTCOMES MATCHED WITH METEOROLOGICAL DATA. Annals of the Rheumatic Diseases. 82. 408–408. 1 indexed citations

Lopatina, Elena, Deborah A. Marshall, Louis Coupal, Jacques Le Lorier, & D. Choquette. (2020). Cost–utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis. Current Medical Research and Opinion. 37(1). 157–166. 6 indexed citations

Choquette, D., Louis Bessette, Frédéric Massicotte, et al.. (2019). AB0740 USE OF SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS. IMPACTS OF COMBINATION WITH METHOTREXATE. Annals of the Rheumatic Diseases. 78. 1835–1835. 3 indexed citations

Baerwald, Christoph, Francesco Saverio Mennini, José Manuel Rodríguez Heredia, et al.. (2017). Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada. Rheumatology International. 37(7). 1111–1123. 10 indexed citations

Rahman, Proton, D. Choquette, W. Bensen, et al.. (2016). Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis. BMJ Open. 6(4). e009661–e009661. 12 indexed citations

10.

Courvoisier, Delphine S., D. Alpizar-Rodriguez, Jacques‐Eric Gottenberg, et al.. (2016). Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study. EBioMedicine. 11. 302–306. 23 indexed citations

11.

Choquette, D., et al.. (2015). Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry. The Journal of Rheumatology. 42(7). 1105–1111. 45 indexed citations

12.

Thorne, Carter, W. Bensen, D. Choquette, et al.. (2014). Effectiveness and Safety of Infliximab in Rheumatoid Arthritis: Analysis From a Canadian Multicenter Prospective Observational Registry. Arthritis Care & Research. 66(8). 1142–1151. 23 indexed citations

13.

Sieper, Joachim, Shankar Srinivasan, Omid Zamani, et al.. (2012). Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Annals of the Rheumatic Diseases. 72(10). 1621–1627. 94 indexed citations

14.

Pelletier, Jean‐Pierre, J.-P. Raynauld, F. Abram, et al.. (2008). A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI. Osteoarthritis and Cartilage. 16. S8–S13. 89 indexed citations

15.

Martel‐Pelletier, Johanne, Peter Bias, Stefan Laufer, et al.. (2008). Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Annals of the Rheumatic Diseases. 68(6). 938–947. 134 indexed citations

16.

Raynauld, J. P., Johanne Martel‐Pelletier, F. Abram, et al.. (2007). Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Annals of the Rheumatic Diseases. 67(5). 683–688. 162 indexed citations

17.

Panopalis, Pantelis, Michelle Petri, Susan Manzi, et al.. (2007). The systemic lupus erythematosus Tri‐Nation study: Cumulative indirect costs. Arthritis Care & Research. 57(1). 64–70. 52 indexed citations

18.

Labelle, Martin, Michèle Beaulieu, Daniel Paquette, et al.. (2004). An integrated approach to improving appropriate use of anti-inflammatory medication in the treatment of osteoarthritis in Québec (Canada): the CURATA model. Medical Teacher. 26(5). 463–470. 6 indexed citations

19.

Pelletier, Jean-Pierre, D. Choquette, Boulos Haraoui, et al.. (1999). Pharmacologic therapy of osteoarthritis. Current Rheumatology Reports. 1(1). 54–58. 4 indexed citations

20.

Dobkin, Patricia L., Deborah Da Costa, Maria Dritsa, et al.. (1999). Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physical health. Arthritis & Rheumatism. 12(6). 401–410. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact